Ratings Becton, Dickinson and Company

Equities

BDX

US0758871091

Market Closed - Nyse 04:00:02 2024-04-18 pm EDT 5-day change 1st Jan Change
233.2 USD +0.40% Intraday chart for Becton, Dickinson and Company -3.10% -4.38%

Summary

  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
  • The company has a good ESG score relative to its sector, according to Refinitiv.

Strengths

  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • For the past twelve months, EPS forecast has been revised upwards.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

  • The group shows a rather high level of debt in proportion to its EBITDA.
  • With an expected P/E ratio at 34.52 and 28.01 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • With an enterprise value anticipated at 3.93 times the sales for the current fiscal year, the company turns out to be overvalued.
  • The company is not the most generous with respect to shareholders' compensation.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
-4.38% 67.09B
A
-4.36% 184B
C+
-3.87% 105B
C
+8.23% 51.61B
B-
+15.54% 47.55B
B-
+0.60% 39.95B
B+
+7.16% 27.62B
A-
-12.48% 25.74B
B
-1.68% 25.62B
B
+11.40% 24.93B
A-
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. BDX Stock
  4. Ratings Becton, Dickinson and Company